Free Trial

Zacks Research Forecasts Weaker Earnings for Select Medical

Select Medical logo with Medical background

Select Medical Holdings Co. (NYSE:SEM - Free Report) - Investment analysts at Zacks Research lowered their Q4 2024 EPS estimates for Select Medical in a note issued to investors on Thursday, November 14th. Zacks Research analyst Z. Masood now expects that the health services provider will earn $0.30 per share for the quarter, down from their prior forecast of $0.31. The consensus estimate for Select Medical's current full-year earnings is $2.16 per share. Zacks Research also issued estimates for Select Medical's Q1 2025 earnings at $0.62 EPS, Q2 2025 earnings at $0.59 EPS, Q4 2025 earnings at $0.47 EPS, FY2025 earnings at $2.14 EPS, Q3 2026 earnings at $0.56 EPS and FY2026 earnings at $2.44 EPS.

Several other research analysts have also weighed in on the stock. Royal Bank of Canada increased their target price on shares of Select Medical from $40.00 to $47.00 and gave the stock an "outperform" rating in a research note on Monday, November 4th. StockNews.com raised shares of Select Medical from a "hold" rating to a "buy" rating in a research note on Wednesday, November 13th. Bank of America assumed coverage on shares of Select Medical in a research note on Tuesday, August 20th. They set a "buy" rating and a $42.00 target price for the company. Finally, Benchmark reissued a "buy" rating and issued a $48.00 price objective on shares of Select Medical in a research note on Friday, November 1st. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $40.75.

Get Our Latest Research Report on SEM

Select Medical Trading Down 3.0 %

SEM stock traded down $1.13 during mid-day trading on Monday, hitting $36.32. 315,949 shares of the company were exchanged, compared to its average volume of 608,228. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The firm has a market capitalization of $4.70 billion, a P/E ratio of 17.50, a PEG ratio of 1.95 and a beta of 1.42. The business has a fifty day simple moving average of $34.81 and a 200-day simple moving average of $34.82. Select Medical has a 12-month low of $22.26 and a 12-month high of $40.98.

Select Medical (NYSE:SEM - Get Free Report) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The firm had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same quarter in the prior year, the firm posted $0.46 earnings per share. Select Medical's quarterly revenue was up 5.7% on a year-over-year basis.

Select Medical Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th will be issued a $0.125 dividend. The ex-dividend date is Wednesday, November 13th. This represents a $0.50 annualized dividend and a yield of 1.38%. Select Medical's dividend payout ratio (DPR) is 23.36%.

Institutional Trading of Select Medical

Several hedge funds have recently added to or reduced their stakes in SEM. Allspring Global Investments Holdings LLC raised its holdings in Select Medical by 6.6% during the first quarter. Allspring Global Investments Holdings LLC now owns 6,563 shares of the health services provider's stock worth $198,000 after purchasing an additional 405 shares in the last quarter. SG Americas Securities LLC acquired a new stake in Select Medical during the first quarter worth approximately $186,000. Russell Investments Group Ltd. raised its holdings in Select Medical by 150.8% during the first quarter. Russell Investments Group Ltd. now owns 92,160 shares of the health services provider's stock worth $2,779,000 after purchasing an additional 55,416 shares in the last quarter. ProShare Advisors LLC raised its holdings in Select Medical by 7.4% during the first quarter. ProShare Advisors LLC now owns 20,984 shares of the health services provider's stock worth $633,000 after purchasing an additional 1,441 shares in the last quarter. Finally, State Board of Administration of Florida Retirement System raised its holdings in Select Medical by 6.2% during the first quarter. State Board of Administration of Florida Retirement System now owns 42,002 shares of the health services provider's stock worth $1,266,000 after purchasing an additional 2,469 shares in the last quarter. Institutional investors and hedge funds own 89.48% of the company's stock.

Select Medical Company Profile

(Get Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Featured Stories

Earnings History and Estimates for Select Medical (NYSE:SEM)

Should you invest $1,000 in Select Medical right now?

Before you consider Select Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.

While Select Medical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines